Efficacy and Safety of Everolimus With Low-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Randomized Study

被引：0
|
作者：
Qazi, Y.
Shaffer, D.
Kaplan, B.
Kim, D.
Luan, F.
Peddi, V.
Shihab, F.
Tomlanovich, S.
Yilmaz, S.
McCague, K.
Patel, D.
Mulgaonkar, S.
机构：
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2014年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
713
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Everolimus With Low-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Randomized Study
    Qazi, Y.
    Shaffer, D.
    Kaplan, B.
    Kim, D.
    Luan, F.
    Peddi, V.
    Shihab, F.
    Tomlanovich, S.
    Yilmaz, S.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    [J]. TRANSPLANTATION, 2014, 98 : 80 - 80
  • [2] Efficacy and Safety of Everolimus Plus Low-Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Data
    Qazi, Y.
    Shaffer, D.
    Kaplan, B.
    Kim, D. Y.
    Luan, F. L.
    Peddi, V. R.
    Shihab, F.
    Tomlanovich, S.
    Yilmaz, S.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (05) : 1358 - 1369
  • [3] 12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients
    Tedesco-Silva, Helio, Jr.
    Vitko, Stefan
    Pascual, Julio
    Eris, Josette
    Magee, John C.
    Whelchel, John
    Civati, Giovanni
    Campbell, Scott
    Alves-Filho, Gentil
    Bourbigot, Bernard
    Garcia, Valter Duro
    Leone, John
    Esmeraldo, Ronaldo
    Rigotti, Paolo
    Cambi, Vincenzo
    Haas, Tomas
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 (01) : 27 - 36
  • [4] Everolimus (Certican) 12-month safety and efficacy versus mycophenolate mofetil in de novo renal transplant recipients
    Vitko, S
    Margreiter, R
    Weimar, W
    Dantal, J
    Viljoen, HG
    Li, YL
    Jappe, A
    Cretin, N
    [J]. TRANSPLANTATION, 2004, 78 (10) : 1532 - 1540
  • [5] Efficacy and Safety of Everolimus with Reduced-Exposure Tacrolimus and Corticosteroid Withdrawal in De Novo Pediatric Renal Transplant Recipients: 12-Month Results from the CRADLE Study
    Ettenger, R.
    Tonshoff, B.
    Tedesco, H.
    Dello Strologo, L.
    Marks, S.
    Pape, L.
    Martzloff, E.
    Rauer, B.
    Ng, J.
    Lopez, P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 407 - 408
  • [6] THE TRANSFORM STUDY: 12-MONTH EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED CALCINEURIN INHIBITOR IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS
    Pascual, Julio
    Berger, Stefan
    Witzke, Oliver
    Chadban, Steve
    Oppenheimer, Federico
    Oberbauer, Rainer
    Watarai, Yoshihiko
    Legendre, Christophe
    Luo, Wen-Lin
    Marti, Anamaria
    Bernhardt, Peter
    Tedesco, Helio
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 159 - 159
  • [7] 12-MONTH ATHENA STUDY: EVEROLIMUS VERSUS STANDARD REGIMEN IN DE NOVO RENAL TRANSPLANT RECIPIENTS
    Sommerer, C.
    Suwelack, B.
    Dragun, D.
    Hauser, I.
    Schenker, P.
    Baeumer, D.
    Nashan, B.
    Thaiss, F.
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 450 - 450
  • [8] EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED TACROLIMUS AND EARLY STEROID ELIMINATION REGIMEN IN DE NOVO PEDIATRIC RENAL TRANSPLANT RECIPIENTS: 12-MONTH DATA FROM THE CRADLE STUDY.
    Toenshoff, B.
    Ettenger, R.
    Christian, M.
    Bjerre, A.
    Strologo, L. D.
    Marks, S. D.
    Pape, L.
    Martzloff, E-D.
    Rauer, B.
    Ng, J.
    Lopez, P. M.
    [J]. PEDIATRIC TRANSPLANTATION, 2017, 21 : 1 - 1
  • [9] Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study
    Jeng, Long-Bin
    Lee, Sung Gyu
    Soin, Arvinder Singh
    Lee, Wei-Chen
    Suh, Kyung-Suk
    Joo, Dong Jin
    Uemoto, Shinji
    Joh, Jaewon
    Yoshizumi, Tomoharu
    Yang, Horng-Ren
    Song, Gi-Won
    Lopez, Patricia
    Kochuparampil, Jossy
    Sips, Carole
    Kaneko, Shuhei
    Levy, Gary
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (06) : 1435 - 1446
  • [10] 12-MONTH ATHENA STUDY: EVEROLIMUS VS. STANDARD REGIMEN IN DE NOVO RENAL TRANSPLANT RECIPIENTS
    Witzke, O.
    Opgenoorth, M.
    Sommerer, C.
    Suwelack, B.
    Lehner, F.
    Dragun, D.
    Hauser, I. A.
    Schenker, P.
    Baeumer, D.
    Nashan, B.
    Thaiss, F.
    [J]. TRANSPLANT INTERNATIONAL, 2014, 27 : 51 - 51
12345